Stephen Locarnini mainly investigates Virology, Hepatitis B virus, Hepatitis B, Immunology and Lamivudine. In his work, Drug is strongly intertwined with Drug resistance, which is a subfield of Virology. His Hepatitis B virus research is within the category of Virus.
His Hepatitis B study incorporates themes from Viral hepatitis, Intensive care medicine, Hepatitis, Public health and Alanine transaminase. The Immunology study combines topics in areas such as Internal medicine and Liver biopsy. His biological study spans a wide range of topics, including Nucleoside analogue, Combination therapy, Transplantation and Reverse-transcriptase inhibitor.
His main research concerns Virology, Hepatitis B virus, Hepatitis B, Immunology and Virus. In his research, Antiviral drug is intimately related to Drug resistance, which falls under the overarching field of Virology. His study in Hepatitis B virus is interdisciplinary in nature, drawing from both Viral load and Genotype.
His Hepatitis B study combines topics in areas such as Gastroenterology, Liver disease, Hepatocellular carcinoma and Viral hepatitis. His Virus study results in a more complete grasp of Genetics. His Lamivudine research incorporates elements of Nucleoside analogue, Famciclovir and Reverse-transcriptase inhibitor.
His primary areas of investigation include Hepatitis B virus, Hepatitis B, Virology, HBsAg and Immunology. His studies in Hepatitis B virus integrate themes in fields like Hepatocellular carcinoma, Viral load and Chronic infection. Stephen Locarnini combines subjects such as Global health, HBeAg, Serology and Intensive care medicine with his study of Hepatitis B.
His Virology research integrates issues from RNA interference, Antigen and Genotype. His study on HBsAg also encompasses disciplines like
Stephen Locarnini spends much of his time researching Hepatitis B, Hepatitis B virus, Virology, Immunology and Internal medicine. His research in Hepatitis B intersects with topics in Epidemiology, Circular DNA, HBeAg and Global health, Public health. His Hepatitis B virus research is multidisciplinary, relying on both Hepatocellular carcinoma, Combination therapy, Genotype and Intensive care medicine.
The study incorporates disciplines such as Genetics and Antigen in addition to Virology. His Immunology research includes themes of Cirrhosis and Therapy naive. Stephen Locarnini has included themes like Gastroenterology, Oncology and Family medicine in his Internal medicine study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.
S. K. Sarin;M. Kumar;G. K. Lau;Z. Abbas.
Hepatology International (2016)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.
Yun Fan Liaw;Jia Horng Kao;Teerha Piratvisuth;Henry Lik Yuen Chan.
Hepatology International (2012)
Persistence of cccDNA During the Natural History of Chronic Hepatitis B and Decline During Adefovir Dipivoxil Therapy
Bettina Werle-Lapostolle;Scott Bowden;Stephen Locarnini;Karsten Wursthorn;Karsten Wursthorn.
Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide: Genotypes, Subgenotypes, and HBsAg Subtypes
Helene Norder;Anne-Marie Couroucé;Pierre Coursaget;José M Echevarria.
Statements from the Taormina expert meeting on occult hepatitis B virus infection.
Giovanni Raimondo;Jean Pierre Allain;Maurizia R. Brunetto;Marie Annick Buendia.
Journal of Hepatology (2008)
Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase
Peter W Angus;Rhys B Vaughan;Shelly Xiong;Huiling Yang.
Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine
D J Tenney;S M Levine;R E Rose;A W Walsh.
Antimicrobial Agents and Chemotherapy (2004)
Molecular virology of hepatitis B virus.
Seminars in Liver Disease (2004)
Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.
Anna S. Lok;Fabien Zoulim;Stephen Locarnini;Angeline Bartholomeusz.
Hepatitis B virus resistance to nucleos(t)ide analogues.
Fabien Zoulim;Fabien Zoulim;Stephen Locarnini.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: